[Effects of interleukin-18 on CD4PD-1 T cells may contribute to the pathogenesis of immune thrombocytopenia].
1/5 보강
The aim of this study was to investigate the regulatory effect and mechanism of interleukin-18 (IL-18) on the function of human peripheral blood CD4 programmed death-1 (PD-1) T cells , and to explore
APA
Cen Yi, Cheng Zhang, et al. (2026). [Effects of interleukin-18 on CD4PD-1 T cells may contribute to the pathogenesis of immune thrombocytopenia].. Sheng li xue bao : [Acta physiologica Sinica], 78(2), 433-442. https://doi.org/10.13294/j.aps.2025.0084
MLA
Cen Yi, et al.. "[Effects of interleukin-18 on CD4PD-1 T cells may contribute to the pathogenesis of immune thrombocytopenia].." Sheng li xue bao : [Acta physiologica Sinica], vol. 78, no. 2, 2026, pp. 433-442.
PMID
42014341 ↗
Abstract 한글 요약
The aim of this study was to investigate the regulatory effect and mechanism of interleukin-18 (IL-18) on the function of human peripheral blood CD4 programmed death-1 (PD-1) T cells , and to explore whether the role of IL-18 was involved in the pathogenesis of immune thrombocytopenia (ITP). Peripheral anticoagulant samples were collected from ITP patients and healthy control subjects, and peripheral blood mononuclear cells (PBMCs) from healthy controls were isolated. CD4PD-1 T cells were isolated by immunomagnetic bead method and used to establish T and B cells co-culture system. ELISA was used to detect the contents of IgG and IgM in cell culture supernatant. Flow cytometry was used to detect cytokine and co-stimulatory molecule expression levels. MitoSOX mitochondrial superoxide indicator was used to detect mitochondrial reactive oxygen species (ROS) levels. The results showed that, under IL-18 stimulation, the expression levels of CD40L and inducible co-stimulator (ICOS) on the surface of healthy control CD4PD-1 T cells were significantly up-regulated, and the abilities of these T cells to assist B cells in producing antibodies were significantly enhanced. IL-18 stimulation increased the mitochondrial ROS levels in healthy control CD4PD-1 T cells, promoting the secretion of interferon γ (IFN-γ) and tumor necrosis factor α (TNF-α) by these T cells. This cytokine secretion promoting effect of IL-18 was inhibited by the ROS scavenger MitoQ. Compared to the healthy controls, the serum soluble PD-1 (sPD-1) level in the ITP patients was significantly increased. Under IL-18 stimulation, the sPD-1 level in the supernatant of healthy control CD4 T cell culture was significantly increased. These results suggest that IL-18 may affect the function of CD4PD-1 T cells by regulating the production of mitochondrial ROS, and participate in their immune regulation through PD-1 pathway, thereby contributing to the pathogenesis of ITP.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Gross-tumor-volume segment-anything model for medical 2D images integrating gross tumor volume-minimal feature integration technology for lung cancer segmentation.
- 5'tRF-GlyGCC Promotes Breast Cancer Progression via LDHA-Mediated Glycolysis and Macrophage Polarization.
- [Application of multi-parametric vital sign monitoring systems in the integrated management of the perioperative stage of gastric cancer].
- MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.